The rising interest in GLP-1 agonists for metabolic conditions has generated a question about delivery methods : skin-applied devices versus pills . Traditionally , GLP-1 treatments were solely available in https://jakubmijs199414.isblog.net/glp-1-skin-applications-vs-pills-is-suitable-for-the-patient-58253911